WALTHAM, Mass., April 7, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (AVTE) ("Aerovate") today announced that, in connection with its previously announced merger ...
Aggregate cash dividend of $69.6 million, or an estimated $2.40 per share WALTHAM, Mass., April 9, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (AVTE) ("Aerovate") today announced that its Board ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results